Trial Profile
Evaluation of the suitability of a 5-ALA patch (PD P 506 A, Alacare) in the photodynamic therapy (PDT) of actinic keratosis on the upper extremities - AK 13
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Sep 2022
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- Acronyms AK 13
- Sponsors Photonamic
- 01 Sep 2022 Results published in the Experimental Dermatology
- 24 Feb 2020 Status changed from active, no longer recruiting to completed.
- 26 Aug 2019 Status changed from recruiting to active, no longer recruiting.